Sara al Dabbas

Sara Al Dabbas is a Clinical Research Associate at MCT-CRO since May 2022, bringing valuable experience from previous roles as a Clinical Research Coordinator at the King Hussein Cancer Foundation and Center from October 2019 to May 2022, and as a Clinical Research Intern at Hikma Pharmaceuticals in 2019. Sara Al Dabbas earned a Doctor of Pharmacy (PharmD) degree with a specialization in Pharmacology from Jordan University of Science and Technology, completing the program from 2012 to 2018.